| Literature DB >> 34184437 |
Sijin Lee1, Sung Woo Lee1, Kap Su Han1, Myung Ki2, Young Hwii Ko3, Su Jin Kim4.
Abstract
BACKGROUND: Survival and post-cardiac arrest care vary considerably by hospital, region, and country. In the current study, we aimed to analyze mortality in patients who underwent cardiac arrest by hospital level, and to reveal differences in patient characteristics and hospital factors, including post-cardiac arrest care, hospital costs, and adherence to changes in resuscitation guidelines.Entities:
Keywords: Cardiac Arrest; Cardiopulmonary Resuscitation; Guideline; Hospital Cost; Hospital Level; Mortality
Year: 2021 PMID: 34184437 PMCID: PMC8239426 DOI: 10.3346/jkms.2021.36.e173
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
Fig. 1Flowchart of the study patient selection.
CPR = cardiopulmonary resuscitation.
Characteristics of patients according to hospital levels
| Variables | Total, No. (%) | Tertiary hospital | General hospital | Hospital | ||
|---|---|---|---|---|---|---|
| Age, yr, mean ± SD (No.) | 64.9 ± 14.8 (109,863) | 67.1 ± 14.7 (167,307) | 72.1 ± 14.0 (59,872) | < 0.001 | ||
| Age group, yr | ||||||
| 20–39 | 15,806 (4.7) | 6,826 (6.2) | 7,437 (4.5) | 1,543 (2.6) | ||
| 40–64 | 111,016 (32.9) | 41,131 (37.4) | 56,498 (33.8) | 13,387 (22.4) | ||
| 65–74 | 86,820 (25.8) | 30,031 (27.3) | 42,633 (25.5) | 14,156 (23.6) | ||
| 75–84 | 89,835 (26.7) | 24,920 (22.7) | 44,771 (26.8) | 20,144 (33.7) | ||
| > 85 | 33,565 (10.0) | 6,955 (6.3) | 15,968 (9.5) | 10,642 (17.8) | ||
| Sex, male | 203,273 (60.3) | 67,916 (61.8) | 102,672 (61.4) | 32,685 (54.6) | < 0.001 | |
| Insurance type | < 0.001 | |||||
| National health insurance | 286,641 (85.1) | 98,185 (89.5) | 141,376 (84.6) | 47,080 (78.7) | ||
| Medical aid | 50,077 (14.9) | 11,571 (10.5) | 25,784 (15.4) | 12,722 (21.3) | ||
| Urbanization level | < 0.001 | |||||
| Metropolitan | 142,915 (42.5) | 59,016 (53.9) | 64,614 (45.2) | 19,285 (32.3) | ||
| Urban | 142,560 (42.4) | 36,633 (33.4) | 82,247 (57.7) | 23,680 (39.6) | ||
| Rural | 50,633 (15.1) | 13,885 (12.7) | 19,974 (12.0) | 16,774 (28.1) | ||
| Admission through ER | 235,337 (69.8) | 83,507 (76.0) | 132,341 (79.1) | 19,489 (32.6) | < 0.001 | |
ER = emergency room.
Comorbidities of patients according to hospital levels
| Variables | Total, No. (%) | Tertiary hospital | General hospital | Hospital | ||
|---|---|---|---|---|---|---|
| Charlson Comorbidity Index | < 0.001 | |||||
| 0–1 | 115,627 (34.3) | 37,568 (34.2) | 61,230 (36.6) | 16,829 (28.1) | ||
| 2–4 | 122,705 (36.4) | 39,048 (35.5) | 60,420 (36.1) | 23,237 (38.8) | ||
| 5–7 | 60,223 (17.9) | 19,238 (17.5) | 28,638 (17.1) | 12,347 (20.6) | ||
| ≥ 8 | 38,487 (11.4) | 14,009 (12.8) | 17,019 (10.2) | 7,459 (12.5) | ||
| Cancer | 67,183 (19.9) | 26,365 (24.0) | 28,796 (17.2) | 12,022 (20.1) | < 0.001 | |
| Ischemic stroke | 67,025 (19.9) | 18,062 (16.4) | 31,885 (19.1) | 17,078 (28.5) | < 0.001 | |
| Hemorrhagic stroke | 12,648 (3.8) | 3,190 (2.9) | 5,529 (3.3) | 3,929 (6.6) | < 0.001 | |
| Ischemic heart disease | 72,198 (21.4) | 25,117 (22.9) | 35,273 (21.1) | 11,808 (19.7) | < 0.001 | |
| Heart failure | 39,152 (11.6) | 12,435 (11.3) | 19,233 (11.5) | 7,484 (12.5) | < 0.001 | |
| Arrhythmia | 33,635 (10.0) | 11,515 (10.5) | 16,170 (9.7) | 5,950 (9.9) | < 0.001 | |
| Hypertension | 188,119 (55.8) | 59,575 (54.2) | 92,927 (55.5) | 35,617 (59.5) | < 0.001 | |
| Hypertension + medicationa | 134,121 (39.8) | 44,157 (40.2) | 68,359 (40.9) | 21,605 (36.1) | < 0.001 | |
| Diabetes mellitus | 117,736 (34.9) | 38,747 (35.3) | 58,602 (35.0) | 20,387 (34.1) | < 0.001 | |
| Diabetes mellitus + medicationb | 63,933 (19.0) | 21,486 (19.6) | 33,086 (19.8) | 9,361 (15.6) | < 0.001 | |
| Chronic pulmonary disease | 105,599 (31.3) | 31,931 (29.1) | 51,961 (31.1) | 21,707 (36.3) | < 0.001 | |
| Chronic renal failure | 30,266 (9.0) | 11,081 (10.1) | 15,232 (9.1) | 3,953 (6.6) | < 0.001 | |
aHypertension + medication, patients with hypertension taking antihypertensive medication; bDiabetes mellitus + medication, patients with diabetes mellitus taking antihyperglycemic agents.
Medications, procedures, outcomes of patients according to hospital levels
| Variables | Total, No. (%) | Tertiary hospital | General hospital | Hospital | |
|---|---|---|---|---|---|
| Defibrillation | 97,805 (29.0) | 32,065 (29.2) | 52,203 (31.2) | 13,537 (22.6) | < 0.001 |
| Epinephrine | 304,928 (90.5) | 104,384 (95.0) | 154,509 (92.4) | 46,035 (76.9) | < 0.001 |
| Atropine | 218,748 (64.9) | 73,523 (66.9) | 111,604 (66.7) | 33,621 (56.2) | < 0.001 |
| Amiodarone | 45,825 (13.6) | 20,879 (19.0) | 24,032 (14.4) | 914 (1.5) | < 0.001 |
| Coronary angiography | 20,756 (6.2) | 10,473 (9.5) | 10,216 (6.1) | 67 (0.1) | < 0.001 |
| PCI | 13,206 (3.9) | 6,420 (5.8) | 6,741 (4.0) | 45 (0.1) | < 0.001 |
| CABG | 1,041 (0.3) | 720 (0.7) | 320 (0.2) | 1 (0.0) | < 0.001 |
| CRRT | 23,356 (6.9) | 13,265 (12.1) | 10,056 (6.0) | 35 (0.1) | < 0.001 |
| Brain CT | 67,728 (20.1) | 26,682 (24.3) | 36,047 (21.6) | 4,999 (8.4) | < 0.001 |
| Brain MRI | 15,802 (4.7) | 7,159 (6.5) | 8,176 (4.9) | 467 (0.8) | < 0.001 |
| EEG | 15,907 (4.7) | 8,892 (8.1) | 6,887 (4.1) | 128 (0.2) | < 0.001 |
| TTM | 3,064 (0.9) | 2,264 (2.1) | 800 (0.5) | 0 (0.0) | < 0.001 |
| 30-day mortality | 284,976 (84.2) | 89,687 (81.6) | 141,197 (84.4) | 54,092 (90.4) | < 0.001 |
| 6-mon mortality | 306,695 (92.7) | 97,854 (89.1) | 152,236 (91.0) | 56,605 (94.5) | < 0.001 |
| 1-yr mortality | 309,661 (93.6) | 98,981 (90.1) | 153,752 (92.0) | 56,928 (95.1) | < 0.001 |
PCI = percutaneous coronary intervention, CABG = coronary artery bypass graft, CRRT = continuous renal replacement therapy, CT = computed tomography, MRI = magnetic resonance imaging, EEG = electroencephalogram, TTM = targeted temperature management.
Multiple logistic analysis for short-, mid-, and long-term mortality by hospital levels
| Variables | Death within 30 days | Death within 6 mon | Death within 1 yr | ||||||
|---|---|---|---|---|---|---|---|---|---|
| aORa | 95% CI | aOR | 95% CI | aOR | 95% CI | ||||
| Tertiary | 0.372 | (0.358–0.386) | < 0.001 | 0.504 | (0.480–0.529) | < 0.001 | 0.538 | (0.511–0.566) | < 0.001 |
| General | 0.419 | (0.404–0.434) | < 0.001 | 0.568 | (0.542–0.595) | < 0.001 | 0.604 | (0.575–0.634) | < 0.001 |
| Hospital | 1 | - | - | 1 | - | - | 1 | - | - |
aOR = adjusted odds ratio, CI = confidence interval.
aAdjusted for age, sex, insurance type, urbanization level, admission route, comorbidities, defibrillation, medication (epinephrine and atropine), angiography, and guideline change through logistic regression analysis of the relationship between level of hospital on death within 30 days, 6 months, and 1 year.
Hospitalization days and hospital costs according to hospital levels
| Variables | Tertiary hospital | General hospital | Hospital | |
|---|---|---|---|---|
| Hospitalization days | 9.6 ± 16.01 (109,863) | 8.32 ± 14.57 (167,307) | 7.66 ± 10.74 (59,872) | < 0.001 |
| ICU days | 8.94 ± 13.37 (54,071) | 8.25 ± 12.55 (80,123) | 7.06 ± 9.57 (6,758) | < 0.001 |
| Hospital costs (USD) during 30-day stay | 5,486 ± 7,645 (109,863) | 3,167 ± 4,649 (167,307) | 1,086 ± 1,532 (59,872) | < 0.001 |
| Hospital costs (USD) from 30-day to 1-yr stay | 19,702 ± 24,746 (12,841) | 15,274 ± 19,213 (16,964) | 11,723 ± 15,596 (3,543) | < 0.001 |
ICU = intensive care unit.
1 USD = 1,155 W.
Medications and procedures before and after guideline changes, by hospital levels
| Variables | Tertiary hospital | General hospital | Hospital | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Before | After | Before | After | Beforea | Afterb | ||||
| Defibrillation | 16,333 (32.0) | 15,732 (26.8) | < 0.001 | 26,507 (34.8) | 25,696 (28.2) | < 0.001 | 7,606 (22.5) | 5,931 (22.8) | 0.338 |
| Epinephrine | 56,344 (95.8) | 48,040 (94.1) | < 0.001 | 85,251 (93.6) | 69,258 (90.9) | < 0.001 | 21,165 (81.4) | 24,870 (73.5) | < 0.001 |
| Atropine | 46,720 (91.5) | 26,803 (45.6) | < 0.001 | 65,580 (86.1) | 46,024 (50.5) | < 0.001 | 19,109 (56.4) | 14,512 (55.8) | 0.104 |
| Amiodarone | 9,152 (17.9) | 11,727 (20.0) | < 0.001 | 9,962 (13.1) | 14,070 (15.4) | < 0.001 | 341 (1.0) | 573 (2.2) | < 0.001 |
| CAG | 4,146 (8.1) | 6,327 (10.8) | < 0.001 | 3,607 (4.7) | 6,609 (7.3) | < 0.001 | 23 (0.1) | 44 (0.2) | < 0.001 |
| PCI | 2,642 (5.2) | 3,778 (6.4) | < 0.001 | 2,388 (3.1) | 4,353 (4.8) | < 0.001 | 15 (0.1) | 30 (0.1) | 0.002 |
| CAGB | 377 (0.7) | 343 (0.6) | 0.002 | 150 (0.2) | 170 (0.2) | 0.632 | 1 (0.0) | 0 (0.0) | 0.381 |
| ECMO | 515 (1.0) | 2,103 (3.6) | < 0.001 | 243 (0.3) | 1,061 (1.2) | < 0.001 | 0 (0.0) | 1 (0.0) | 0.657 |
| ETCO2 | 1,969 (3.9) | 7,747 (13.2) | < 0.001 | 1,584 (2.1) | 4,938 (5.4) | < 0.001 | 62 (0.2) | 4 (0.0) | < 0.001 |
| CRRT | 5,031 (9.9) | 8,234 (14.0) | < 0.001 | 3,453 (4.5) | 6,603 (7.3) | < 0.001 | 12 (0.1) | 23 (0.1) | 0.008 |
| Brain CT | 12,207 (23.9) | 14,475 (24.6) | 0.006 | 16,735 (22.0) | 19,312 (21.2) | < 0.001 | 2,735 (8.1) | 2,264 (8.7) | 0.006 |
| Brain MRI | 3,366 (6.6) | 3,793 (6.5) | 0.348 | 3,632 (4.8) | 4,544 (5.0) | 0.037 | 230 (0.7) | 237 (0.9) | 0.001 |
| EEG | 3,657 (7.2) | 5,235 (8.9) | < 0.001 | 2,620 (3.4) | 4,267 (4.7) | < 0.001 | 62 (0.2) | 66 (0.3) | 0.064 |
| TTM | 65 (0.1) | 2,199 (3.7) | < 0.001 | 14 (0.1) | 786 (0.9) | < 0.001 | 0 (0.0) | 0 (0.0) | 0.084 |
aBefore: January 2006 to December 2010, bAfter: January 2011 to December 2015.
CAG = coronary angiography, PCI = percutaneous coronary intervention, CABG = coronary artery bypass graft, ECMO = extracorporeal membrane oxygenation, ETCO2 = end tidal carbon dioxide, CRRT = continuous renal replacement therapy, CT = computed tomography, MRI = magnetic resonance imaging, EEG = electroencephalogram, TTM = targeted temperature management.